Patents Represented by Attorney, Agent or Law Firm Rae-Venter Law Group P.C.
-
Patent number: 6159713Abstract: Methodology is provided for developing probes for identifying sequence differences between two related DNA populations, sets of DNA fragments or collections of restriction-endonuclease-cleaved DNA or cDNA. The method employs an initial stage to obtain a representation of both DNA populations, namely using the PCR to produce relatively short fragments, referred to as amplicons. Tester amplicons containing target DNA, sequences of interest, are ligated to adaptors and mixed with excess driver amplicons under melting and annealing conditions, followed by PCR amplification. The process may be repeated so as to greatly enrich the target DNA. Optionally, the target DNA may then be cloned and the DNA used as probes.Type: GrantFiled: July 14, 1998Date of Patent: December 12, 2000Assignee: Cold Spring Harbor LaboratoryInventors: Michael Wigler, Nikolai Lisitsyn
-
Patent number: 6149812Abstract: A dental environmental filter is provided for the collection of heavy metals and other particles during dental or other procedures. The dental environmental filter incorporates a manifold with an inlet conduit and an outlet conduit, with an adjustable control handle on the top of the manifold and a baffle plate in the inside of the manifold. The manifold is sealed to the top opening of a collection chamber. During procedures which require withdrawal of fluids, the control handle and baffle plate are adjusted to a fluids mode which connects a internal adjustable conduit, which transverses through the baffle plate, with the lumen of the inlet and outlet conduits to form a continuous lumen with which to withdraw fluids through. During procedures which require the withdrawal of heavy metals or other particles, the control handle and baffle plate are adjusted to a solids mode which orients the baffle plate to face the both the lumen of the inlet and outlet conduits.Type: GrantFiled: October 22, 1998Date of Patent: November 21, 2000Inventor: Roger T. Erickson
-
Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
Patent number: 6140486Abstract: The present invention relates to compositions and methods for preparing poly-unsaturated long chain fatty acids in plants, plant parts and plant cells, such as leaves, roots, fruits and seeds. Nucleic acid sequences and constructs encoding PKS-like genes required for the poly-unsaturated long chain fatty acid production, including the genes responsible for eicosapentenoic acid production of Shewanella putrefaciens and novel genes associated with the production of docosahexenoic acid in Vibrio marinus are used to generate transgenic plants, plant parts and cells which contain and express one or more transgenes encoding one or more of the PKS-like genes associated with such long chain polyunsaturated fatty acid production. Expression of the PKS-like genes in the plant system permits the large scale production of poly-unsaturated long chain fatty acids such as eicosapentenoic acid and docosahexenoic acid for modification of the fatty acid profile of plants, plant parts and tissues.Type: GrantFiled: June 4, 1998Date of Patent: October 31, 2000Assignee: Calgene LLCInventors: Daniel Facciotti, James George Metz, Michael Lassner -
Patent number: 6124528Abstract: This invention relates to methods for the expression of sucrose phosphate synthase encoding sequences alone or in cooperation with sugar metabolizing enzyme sequences to modify the soluble solids in plant fruit tissue. Depending on whether sense or antisense sequences are used, the method permits an increased or decreased sweetness in plant fruit tissue, such as tomato fruit.Type: GrantFiled: April 6, 1998Date of Patent: September 26, 2000Assignee: Calgene LLCInventor: Christine Shewmaker
-
Patent number: 6123928Abstract: Novel polymeric biologically inert compositions and their intermediates, as well as sunscreen formulations comprising them and making them invisible, are provided for broad range protection from ultraviolet radiation. Acryl polymers comprising at least two different ultraviolet absorbing moieties having different light absorbing ranges are employed in conjunction with other monomers to provide sunscreen polymers as microparticles. The polymer microparticles, once imbibed with carrier compounds, change the refractive index, thus providing invisible sunscreen formulations which offer enhanced protection without adverse physiological effects.Type: GrantFiled: July 21, 1998Date of Patent: September 26, 2000Assignee: Biophysica, Inc.Inventors: Milos Sovak, Ronald C. Terry, James G. Douglass, III, Farid Bakir, Jason Brown, Peter Cugley
-
Patent number: 6117872Abstract: NO precursors are administered at elevated levels in addition to the diet of the individual to enhance exercise performance. Particularly, L-arginine and L-lysine by enhancing endothelial NO production can provide for greater aerobic capacity and improved exercise performance.Type: GrantFiled: June 23, 1998Date of Patent: September 12, 2000Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Andrew J. Maxwell, John P. Cooke
-
Patent number: 6103537Abstract: The present invention concerns methods for masking inhomogeneity of a member of a specific binding pair (sbp) employed in a capillary electroseparation. The method comprises binding the sbp member to synthetic particles that become localized during capillary electroseparation. Also disclosed is one embodiment of the present invention, which is a method for conducting a capillary electroseparation specific binding assay. The method involves the electroseparation of a labeled first member of a specific binding pair that is bound in a complex from labeled first member that is not bound in the complex. The complex comprises the first member and a second member of a specific binding pair. A combination is provided comprising a sample suspected of containing an analyte, a labeled first member of a specific binding pair, and a second member of a specific binding pair under conditions for forming a complex between labeled first member and the second member.Type: GrantFiled: September 30, 1998Date of Patent: August 15, 2000Assignee: ACLARA Biosciences, Inc.Inventors: Edwin F. Ullman, Gregory B. Stauber
-
Patent number: 6103199Abstract: The present invention concerns an apparatus for conducting a microfluidic process. The apparatus comprises integral first and second plates. The first plate comprises an array of sample receiving elements for receiving a plurality of samples from an array of sample containers and dispensing the samples. The second plate comprises a planar array of microfluidic networks of cavity structures and channels for conducting a microfluidic process. Also disclosed is a method for processing an array of samples. At least a portion of each sample in an array of sample wells is simultaneously transferred to a corresponding array of microfluidic networks of cavity structures and channels by means of a corresponding array of sample receiving elements that is in integral fluid communication with the array of microfluidic networks. The samples are then processed.Type: GrantFiled: September 15, 1998Date of Patent: August 15, 2000Assignee: ACLARA Biosciences, Inc.Inventors: Torleif Ove Bjornson, Randy M. McCormick, David S. Soane
-
Patent number: 6096547Abstract: Constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: GrantFiled: July 31, 1998Date of Patent: August 1, 2000Assignee: Calgene, LLCInventors: Robert M. Goodman, Vic C. Knauf, Catherine M. Houck, Luca Comai
-
Patent number: 6093296Abstract: Devices and methods are disclosed for moving charged molecules through a medium by the application of a plurality of electrical fields of sufficient strength and applied for sufficient amounts of time so as to move the charged molecules through the medium. The devices although preferably small in size, preferably generate large numbers (100 or more) of electrical fields to a movement area which preferably contains a liquid buffered or gel medium. Mixtures of charged molecules are pulled through the gel by the force of the electrical fields. The fields are preferably activated simultaneously or sequentially one after another at various speeds to create complex force field distributions or moving field waves along the separation medium. Charged molecules capable of moving quickly through the gel will be moved along by the faster moving field waves and be separated from slower moving molecules.Type: GrantFiled: November 19, 1997Date of Patent: July 25, 2000Assignee: ACLARA Biosciences, Inc.Inventors: David S. Soane, Zoya M. Soane
-
Patent number: 6074827Abstract: Integrated microfluidic devices comprising at least an enrichment channel and a main electrophoretic flowpath are provided. In the subject integrated devices, the enrichment channel and the main electrophoretic flowpath are positioned so that waste fluid flows away from said main electrophoretic flowpath through a discharge outlet. The subject devices find use in a variety of electrophoretic applications, including clinical assays, high throughput screening for genomics and pharmaceutical applications, point-or-care in vitro diagnostics, molecular genetic analysis and nucleic acid diagnostics, cell separations, and bioresearch generally.Type: GrantFiled: February 5, 1998Date of Patent: June 13, 2000Assignee: ACLARA Biosciences, Inc.Inventors: Robert J. Nelson, Herbert H. Hooper, Alan K. Hauser, Sharat Singh, Stephen J. Williams, Alexander P. Sassi
-
Patent number: 6071520Abstract: Novel proteins of the Chicken Anemia Virus are described and compositions for preventing or treating infections with that virus (CAV), in particular vaccines less pathogenic than the CAV itself, but yet leading to neutralizing antibodies in the immunized animal. Besides, there are described compositions containing antibodies against parts of the CAV for the control of infections with CAV and anti-idiotype antibodies. The invention also provides antibodies and test kits for the detection of CAV. Recombinant DNA molecules derived from CAV and host cells transfected therewith and vaccines based on these host cells are made possible by this invention. The invention also comprises living virus vaccines in which a piece of DNA is brought into a virus infectious to the host. Besides, the invention provides uses of proteins of CAV in the induction of apoptosis, in particular in tumor cells. It further provides the induction of cell death by means of gene therapy.Type: GrantFiled: November 30, 1995Date of Patent: June 6, 2000Assignee: Leadd BVInventors: Mathieu Hubertus Maria Noteborn, Guus Koch
-
Patent number: 6072069Abstract: Novel non-ionic contrast media are provided, which fulfill the requirements for x-ray visualization media, while being biodegradable. The compounds are characterized by being triiodo-3,5-diaminobenzoic acid derivatives, where the functional groups are derivatized with hydroxyalkyl groups and the amino functionalities are further derivatized with acyl substituents of one carbon acids. Also, triiodophloroglucinol oxyalkyl substituted derivatives are provided.Type: GrantFiled: November 4, 1998Date of Patent: June 6, 2000Assignee: Biophysica, Inc.Inventors: Milos Sovak, Allen L. Seligson, James Gordon Douglass, III
-
Patent number: 6063432Abstract: Health bars are provided having high dosages of at least one of the amino acids L-arginine and L-lysine in conjunction with fruit solids and paste, protein and carbohydrates. A number of different fruit sources may be used, grapes finding particular use, and soy being a useful source of proteins. The bars are made by preparing a syrup at an elevated temperature, adding a fruit paste and cooling, followed by the addition of minor ingredients and mixing, the amino acids and a portion of the protein and mixing, followed by the remaining ingredients and formation as a bar.Type: GrantFiled: May 19, 1998Date of Patent: May 16, 2000Assignee: Cooke PharmaInventors: Andrew J. Maxwell, John P. Cooke, Thomas Martin Radke
-
Patent number: 6056860Abstract: Electrophoretic chambers having at least a region of surface modification, and methods for their fabrication, are provided. In some embodiments the subject chambers include in the region of surface modification an anchoring polymeric layer interpenetrating the surface of the chamber and an electrophoretic polymeric layer copolymerized with the anchoring polymeric layer. The subject chambers are prepared by sequentially contacting the chamber surface with a first monomer capable of interpenetrating the surface and a second monomer capable of copolymerization with the first monomer, followed by copolymerization of the first and second monomers. In other embodiments an electrophoretic polymeric layer is noncovalently bound on the surface of a rigid polymereic base material without the aid of a separate anchoring polymeric layer. The subject devices find use in any of a variety of electrophoretic applications in which entities are moved through a medium under the influence of an applied electric field.Type: GrantFiled: September 18, 1997Date of Patent: May 2, 2000Assignee: ACLARA Biosciences, Inc.Inventors: M. Goretty Alonso Amigo, Randy M. McCormick
-
Patent number: 6054034Abstract: Microchannels having at least an acrylic inner surface and methods of their use in electrophoretic applications are provided. The subject microchannels may be in the form of a variety of configurations suitable for holding an electrophoretic medium. The subject microchannels give rise to substantially reduced EOF and/or adsorption as compared to fused silica under conditions of electrophoresis and find use in a variety of electrophoretic applications in which charged entities are moved through a medium under the influence of the an applied electric field.Type: GrantFiled: May 9, 1997Date of Patent: April 25, 2000Assignee: ACLARA Biosciences, Inc.Inventors: David S. Soane, Zoya M. Soane, Herbert H. Hooper, M. Goretty Alonso Amigo
-
Patent number: 6048715Abstract: A two-phase partition system is provided for affinity separation of a composition containing a polysaccharide binding peptide from a mixture such as a fermentation broth. The peptide may be from an enzyme and lacking in polysaccharidase activity such as the binding domain of cellulase that binds to cellulose. The system contains a phase-forming oligosaccharide polymer such as a cellulose derivative to which the peptide binds with a Ka of 10.sup.3 M to 10.sup.7 M, and a phase inducing agent such as a polyethylene glycol polymer, or a salt present at sufficiently high concentration to induce phase separation. If the oligosaccharide polymer is thermoseparating, phase separation can be induced by heating. Using the system involves contacting a composition containing the peptide such as a fusion protein with the system, partitioning the composition into a phase containing the oligosaccharide polymer by binding to the polymer and recovering the polymer containing the bound composition.Type: GrantFiled: July 24, 1996Date of Patent: April 11, 2000Assignee: Univ. of British ColumbiaInventors: Charles A. Haynes, Peter Tomme, Douglas G. Kilburn
-
Patent number: 6046455Abstract: Diyne monomers are used as photochromic agents in devices or formulations. The devices and formulations may be applied to body parts for semi-pemanent attachment at various sites to allow for detection of levels of ultraviolet radiation. Clear films may be placed on eyeglass lenses to detect UV radiation occurring between the lens and the eye.Type: GrantFiled: January 30, 1998Date of Patent: April 4, 2000Assignee: Segan IndustriesInventors: Hans O. Ribi, David A. Frankel
-
Patent number: 6033908Abstract: The invention provides improved methods and products based on adenoviral materials which can advantageously be used in for instance gene therapy. In one aspect an adenoviral vector is provided which has no overlap with a suitable packaging cell line which is another aspect of invention. This combination excludes the possibility of homologous recombination, thereby excluding the possibility of the formation of replication competent adenovirus. In another aspect an adenovirus based helper construct which by its size is incapable of being encapsidated. This helper virus can be transferred into any suitable host cell making it a packaging cell. Further a number of useful mutations to adenoviral based materials and combinations of such mutations are disclosed, which all have in common the safety of the methods and the products, in particular avoiding the production of replication competent adenovirus and/or interference with the immune system. Further a method of intracellular amplification is provided.Type: GrantFiled: July 15, 1997Date of Patent: March 7, 2000Assignee: IntroGene, b.v.Inventors: Abraham Bout, Robert Cornelis Hoeben
-
Patent number: 6007690Abstract: Integrated microfluidic devices comprising at least an enrichment channel and a main electrophoretic flowpath are provided. In the subject integrated devices, the enrichment channel and the main electrophoretic flowpath are positioned so that waste fluid flows away from said main electrophoretic flowpath through a discharge outlet. The subject devices find use in a variety of electrophoretic applications, including clinical assays, high throughput screening for genomics and pharmaceutical applications, point-or-care in vitro diagnostics, molecular genetic analysis and nucleic acid diagnostics, cell separations, and bioresearch generally.Type: GrantFiled: July 30, 1997Date of Patent: December 28, 1999Assignee: Aclara Biosciences, Inc.Inventors: Robert J. Nelson, Herbert H. Hooper, Alan K. Hauser, Alexander P. Sassi